University of Hong Kong
Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 22 cancer immunotherapy PhD Projects, Programmes & Scholarships
cancer immunotherapy PhD Projects, Programmes & Scholarships
We have 22 cancer immunotherapy PhD Projects, Programmes & Scholarships
PhD saved successfully
PhD in Infection, Immunity, Antimicrobial Resistance & Repair - Developing virus-based cancer vaccines with molecular enhancers
Summary. Cancer immunotherapy has revolutionised the field of oncology. This project uses molecular enhancement of an established vaccine platform to develop cancer vaccines with increased potency. Read more
Engineering, characterisation and glycoprofiling of IgE antibodies for cancer immunotherapy
Half of patients with melanoma, the most lethal skin cancer, and a large proportion of patients with aggressive breast cancers such as the triple negative subtypes, do not respond to currently available antibody immunotherapies. Read more
Understanding what makes a new class of memory natural killer (NK) cells an optimal candidate for cancer immunotherapy
Immunotherapies have changed the paradigm of cancer treatment away from conventional cytotoxic chemotherapy. However, immunotherapy outcomes remain more limited in acute myeloid leukaemia (AML) than in other settings, e.g., acute lymphoblastic leukaemia. Read more
Develop single-cell biomechanical nanotools for novel cardiovascular mechanobiology and cancer immunotherapy
In view of the high complexity and dynamics of protein complexes that perform important physiological functions, it is difficult to visualise and characterise their kinetic and signaling processes on single living cells using traditional biochemical and biophysical techniques. Read more
Cancer: Complex 3D modelling of the tumour microenvironment for immunotherapy combination screening
Cancer immunotherapy holds significant promise for the treatment of a range of cancers. Read more
Cancer: Understanding the immunosuppressive role of fibroblast and macrophages in Breast cancer
Oncolytic viruses (OVs) preferentially infect and kill cancer cells, and their clinical efficacy has been demonstrated against a number of different cancers. The most clinically advanced OV is a genetically engineered herpes simplex virus (T-VEC) which expresses GMCSF to aid the development of anti-tumour immune responses; T-VEC is approved for the treatment of metastatic melanoma. Read more
Last chance to apply
Mechanisms of cancer immune evasion and immunotherapy sensitivity in a unique human model of immune regulation
Mechanisms of cancer immune evasion and immunotherapy sensitivity in a unique human model of immune regulation. Read more
PhD studentship studying the Cancer Microenvironment and Immunotherapy
We wish to recruit motivated PhD research students to join the translational cancer / lymphoma immunology group led by Dr Alan G. Read more
Examining How Thymus Stromal Cells Control T Cell Development
We are seeking talented, motivated students with a passion for research in T-cell development and thymus biology to study under the supervision of Dr William Jenkinson. Read more
Dual receptor binding radiopharmaceuticals in cancer: targeting the CXCR4 and ACKR3 chemokine receptors
Applications are invited for a fully funded 3,5 year full-time PhD studentship (including home tuition fees, annual stipend and consumables) starting on 1st February 2024. Read more
Liver immunology, regeneration and viral infection projects (SARS-CoV-2, hepatitis viruses)
We are seeking talented, motivated students with a passion for immunology research to join the Viral and Liver Immunology group led by Dr Zania Stamataki. Read more
Imaging-based analysis of signalling pathways triggered by immune checkpoint receptors
Commercial partner: Gilead Sciences (Oxford). Read more
Research Postgraduate Studies @HKUMed 2024/25
Master of Philosophy and Doctor of Philosophy applications start 1 Sep 2023! Get your hands on our latest pamphlet, contact your new supervisor NOW and apply before 1 Dec 2023. Read more
Understanding and exploiting antigen discrimination by T cells
T cells use their T-cell receptors (TCRs) to discriminate between lower-affinity self and higher affinity non-self pMHC antigens. Read more
Developing a pre-clinical human pancreatic cancer model to test novel immunotherapies.
Background. Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers in humans. There is a high unmet medical need to develop new therapies for the treatment of this disease. Read more
- 1
- 2